Uni-Bio Science Group Limited
UNBSF
$0.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.31% | 10.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.31% | 10.97% | |||
| Cost of Revenue | -0.31% | 14.76% | |||
| Gross Profit | -0.31% | 10.16% | |||
| SG&A Expenses | -0.31% | -5.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.38% | 69.03% | |||
| Total Operating Expenses | -0.31% | -7.47% | |||
| Operating Income | -0.31% | 163.71% | |||
| Income Before Tax | -0.31% | 300.43% | |||
| Income Tax Expenses | -0.29% | -36.45% | |||
| Earnings from Continuing Operations | -0.31% | 393.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.31% | 393.13% | |||
| EBIT | -0.31% | 163.71% | |||
| EBITDA | -0.31% | 160.87% | |||
| EPS Basic | 0.00% | 300.00% | |||
| Normalized Basic EPS | 0.00% | 400.00% | |||
| EPS Diluted | 0.00% | 300.00% | |||
| Normalized Diluted EPS | 0.00% | 400.00% | |||
| Average Basic Shares Outstanding | 0.00% | -2.38% | |||
| Average Diluted Shares Outstanding | 0.00% | -2.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||